[Latin Name] Allium sativum L.

[Plant Source] from China

[Appearance] Off-white to light yellow Powder

Plant Part Used:Fruit

[Particle size] 80 Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

Introduction:

In ancient times, garlic was used as a remedy for intestinal disorders, flatulence, worms, respiratory infections, skin diseases, wounds, symptoms of aging, and many other ailments. To date, more than 3000 publications from all over the world have gradually confirmed the traditionally recognized health benefits of garlic.

Although aged Garlic has so many benefits to human body, but it has a unpleasant odor. most of people do not like this taste ,so we use modern biological technology, to enrichment the elite containing in the Garlic and get rid of the odor of the product ,we call it aged garlic extract

Function:

(1) Has a strong and extensive antibiotic ability. It can kill all kinds of bacteria totally sucn as gram-positive bacteria, gram-negative bacteria and fungi; can restrain and kill some pathogenic microorganisms such as many staphylococcocci, pasteurella, typhoid bacillus, shigella dysenteriae and pseudomonas aeruginosa. So, it can prevent and cure many kinds of contagion, especially coccidiosis in chicken.

(2) Because of its strong garlic odour, allicin can increase feed intake of the birds and fish.

(3) Flavors the meals with a uniform garlic smell and mask unpleasant odors of various feed components.

(4) Strengthen immune system, and promote healthy growth in poultry and fish.

(5) Allicin’s garlic odour is effective in repelling flies, mites and other insects from the feed.

(6) Allicin has a potent sterilization effect on Aspergillus flavus, Aspergillus Niger, Aspergillus fumigatus, etc. and is therefore able to prevent the onset of feed mildew and prolong feed life.

(7) Allicin is safe with no residual drugs

Full title: Cures for Malaria, Tuberculosis, Alzheimer’s? An Update on Natural Products Discovery at HBOI

About the Speaker

Dr. Amy Wright is formally trained as an organic chemist and has spent the past 35 years exploring the chemistry of marine organisms with the goal of identifying natural products with the potential to change how we treat dread diseases. Much of her work has focused on organisms collected in deep water habitats using tools such as the Johnson-Sea-Link submersibles. She received her B.S. from California State University at Dominguez Hills and her MSc and Ph.D. in Organic Chemistry from the University of California at Riverside.

About the Lecture

Wherever there is biological diversity there is chemical diversity and this diversity leads to opportunities for finding new medicines. Many plants, marine animals and microbes produce small organic molecules, “natural products”, that provide advantages to the organisms that make them which range from attracting mates to repelling or even poisoning predators.

These same natural products often show activity in human health applications and over 46% of the small molecule medicines used today have their origin in natural products. The talk will discuss the HBOI natural products library and how we are using it to look for new compounds with the potential to treat cancer, tuberculosis, multi-drug resistant bacterial infections, and Alzheimer’s disease.

Title: Craft materials to overcome ocular barriers

4th International Conference on
Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore, USA

OMICS International: https://omicsonline.org
Vaccine Conferences: https://conferenceseries.com/immunology-conferences.php
Global Medical Conferences: https://conferenceseries.com
Global Pharmaceutical Conferences: https://pharmaceuticalconferences.com
Global Cancer Conferences: https://cancersummit.org

Global Diabetes Conferences: https://diabetesexpo.com
Global Dental Conferences: https://dentalcongress.com
Global Nursing Conferences: https://nursingconference.com

Abstract:

While new therapeutics are being developed for treating ocular diseases, the use of these therapeutics is still hampered by the need for more effective method of delivery. The reason is that these therapeutics have short half-lives, do not or hardly cross the cornea, the blood retinal barrier (BRB) and other ocular barriers, and can cause toxicity and side effects at high dose. In our Biomaterials for Translational Research Laboratory, we are interested in engineering multi-functional polymeric systems for targeted and sustained delivery of desired amount of drugs across ocular barriers to treat anterior and posterior eye diseases. In this talk, I will discuss our collaborative researches in developing i) hydrogels as subconjunctivally implantable delivery systems for sustained release of insulin to treat diabetic retinopathy; and ii) polysaccharide based nanoparticles for enhanced drug permeability across the cornea and the BRB to treat diabetic retinopathy, retinoblastoma, and glaucoma, etc.

Biography:

Tao Lowe is an Associate Professor of Pharmaceutical Sciences and Biomedical Engineering at University of Tennessee. Previously, she was an Assistant Professor of Surgery, Bioengineering, and Materials Science and Engineering, and Co-Director of the Integrated Graduate Degree Molecular Toxicology Program at Pennsylvania State University. She received her Ph.D. with an Eximia Cum Laude from the University of Helsinki, Finland, and conducted two years’ postdoctoral research in the Chemical Engineering Department at University of Wisconsin, Madison. She has published more than two dozen papers in reputed journals, and has given more than 150 presentations and 60 invited talks. She has trained ca. 60 students, including PhD, MD, MD/PhD, PharmD, and PharmD/PhD. She is a peer reviewer for more than 30 refereed journals, and serves on the editorial boards of 6 international journals. She has chaired more than 40 sessions at international conferences.